載入...
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues upon dose escalation, ADCs utilize monoclonal antibodies (mAbs) to specifically bind tumour-associated target antigens and...
Na minha lista:
| 發表在: | Biosci Rep |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Portland Press Ltd.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613712/ https://ncbi.nlm.nih.gov/pubmed/26182432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20150089 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|